✓ Graphs ✓ Tables ✓ Reports
 
Format: www.xyz.com or *.gov
Where ▼
Where ▲
Date:
Note: Results will be PDF and Excel – which we can date reliably. For PDFs, it will either be the date the PDF was creater, or the date visible in the graph or chart.
When ▼
When ▲
What ▼
What ▲

Data & statistics on Arthritis Therapy – 6812 results
Hover over me
Poster Session 1. Rheumatoid arthritis: therapy
277 more results from this site ▶

Poster Session 1. Rheumatoid arthritis: therapy

rheumatology.oxfordjournals.org/cgi/reprint/43/suppl_2/ii43.pdf

Poster Session 1. Rheumatoid arthritis: therapy No. of DMARDs Current ...
Background: Male patients with RA are known to report better function and fewer symptoms than female patients. In the course of a study of comorbidity in RA, current and previous DMARD therapy was documented to ascertain whether gender influenced prescribing ...
on therapy longer. This may influence subsequent prescribing. Physicians may need to alter

Jan 2010 | Oxford Journals | Medicine | Rheumatology – 277 more results from this site
Original Url: http://rheumatology.oxfordjournals.org/cgi/reprint/43/suppl_2/ii43.pdf
CYTOTRON - New Horizons in Cancer & Arthritis Therapies, Kanser, Kemoterapi, Onkoloji, Tьmцr, Kireзlenme, Artrit, Ortopedi, Romatizma , Eklem, Alternatif ...

CYTOTRON - New Horizons in Cancer & Arthritis Therapies, Kanser, Kemoterapi, Onkoloji, Tьmцr, Kireзlenme, Artrit, Ortopedi, Romatizma , Eklem, Alternatif ...

www.cytotron.com/

CYTOTRON - New Horizons in Cancer & Arthritis Therapies, Kanser, Kemoterapi, Onkoloji, Tьmцr, Kireзlenme, Artrit, Ortopedi, Romatizma , Eklem, Alternatif Tıp

May 2009 | www.cytotron.com
Thrombospondin-1 as arthritis therapy

Thrombospondin-1 as arthritis therapy

ir.lib.ncku.edu.tw/bitstream/987654321/44318/1/7011500503010.pdf

Thrombospondin-1 as arthritis therapy

Jun 2004 | ?????????? : ??
Original Url: http://ir.lib.ncku.edu.tw/bitstream/987654321/44318/1/7011500503010.pdf
Olsen et al. Arthritis Research & Therapy 2014, 16:R17 http://arthritis-research.com/content/16/1/R17
878 more results from this site ▶

Olsen et al. Arthritis Research & Therapy 2014, 16:R17 /1/R17

arthritis-research.com/content/pdf/ar4444.pdf

FOS JUN Delta Ct Delta Ct MTX (uM) Olsen et al. Arthritis Research & Therapy 2014, 16:R17 ontent/16/1/R17 consistent with the known adverse events of this treatment. It is possible that specialized monocyte

Jan 2014 | Arthritis Research & Therapy – 878 more results from this site
Original Url: http://arthritis-research.com/content/pdf/ar4444.pdf
Nakayama et al. Arthritis Research & Therapy 2012, 14:R120 http://arthritis-research.com/content/14/3/R120
6 more results from this site ▶

Nakayama et al. Arthritis Research & Therapy 2012, 14:R120 /3/R120

arthritis-research.com/content/pdf/ar3850.pdf

inflammatory diseases. Arthritis Res Ther 2006, 8:R166. Joosten LA, Netea MG, Kim SH, Yoon ...
den Berg WB: IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc Natl ...
Arthritis Rheum 2009, 60:678-685. Ko NY, Mun SH, Lee SH, Kim JW, Kim do K, Kim HS, Her

Jan 2012 | .com – 6 more results from this site
Original Url: http://arthritis-research.com/content/pdf/ar3850.pdf
Application of upper gastrointestinal tract complications (UGIC) risk estimations to the populations of patients included in the control groups (exposed to traditional non-steroidal antiinflammatory drugs) for the Vioxx Gastrointestinal Outcomes Research (VIGOR), Celecoxib Long-term Arthritis Safety Study (CLASS), and Therapeutic Arthritis Research and Gastrointestinal Event Trial

Application of upper gastrointestinal tract complications (UGIC) risk estimations to the populations of patients included in the control groups (exposed to traditional non-steroidal antiinflammatory ...

www.hmc.org.qa/heartviews/vol7No4/PDF/ORIGINAL_ARTICLE3.pdf

the Celecoxib Long-term Arthritis Safety Study (CLASS)22, and the Therapeutic Arthritis

Mar 2007 | Welcome to HAMAD MEDICAL CORPORATION Website
Original Url: http://www.hmc.org.qa/heartviews/vol7No4/PDF/ORIGINAL_ARTICLE3.pdf
Güler-Yüksel et al. Arthritis Research & Therapy 2010, 12:R96 http://arthritis-research.com/content/12/3/R96
49 more results from this site ▶

Güler-Yüksel et al. Arthritis Research & Therapy 2010, 12:R96 /3/R96

www.biomedcentral.com/content/pdf/ar3025.pdf

injections and anti-resorptive therapy (bisphosphonates, calcium and vitamin D suppletion and hormone replacement therapy). ACPA, anti-citrullinated protein antibodies; AUC, area

Jan 2010 | BioMed Central – 49 more results from this site
Original Url: http://www.biomedcentral.com/content/pdf/ar3025.pdf
RHEUMATOID ARTHRITIS: ENZYME THERAPY OF ACTIVE ARTHRITIS

RHEUMATOID ARTHRITIS: ENZYME THERAPY OF ACTIVE ARTHRITIS

www.freedom-from-herpes.com/oral.htm

6 Months Gold Therapy or Oral Enzymes on 51 Rheumatoid Arthritis Patients (Klein et al ...
">RHEUMATOID ARTHRITIS: ENZYME THERAPY OF ACTIVE ARTHRITIS <p id="elem-627" class ...
auto-immune diseases for which enzyme therapy has been used. <ul id="elem-609"> <li

Natural Cure And Medication For Genital Herpes
Percentage of Patients with Rheumatoid Arthritis in the Finnish Rheumatoid Arthritis Combination Therapy Trial Retiring Over 5 Years by Response Group at 6 months. Group I = clinical remission; Group II = ACR-50 response but not remission; Group III = ACR-20 response but not ACR-50 response; Group IV = less than ACR-20 response. p <.001 for difference across groups. Reprinted with permission from reference ...

Percentage of Patients with Rheumatoid Arthritis in the Finnish Rheumatoid Arthritis Combination Therapy Trial Retiring Over 5 Years by Response Group at 6 months. Group I = clinical remission; Group ...

members.home.nl/zamb/Bestanden/Klusters-bestanden/Kluster%20reuma%20ASHP%20Resman.pdf

single-DMARD therapy. A further analysis examined the relationship between response to therapy at six months and permanent disability over five years.21 After adjusting ...
the investigators found that risk correlated with six-month response to therapy in the following

Aug 2006 | members index
Original Url: http://members.home.nl/zamb/Bestanden/Klusters-bestanden/Kluster%20reuma%20ASHP%20Resman.pdf
In a 6 month study of 263 patients with persistent active rheumatoid arthritis despite methotrexate therapy, and with normal LFTs, leflunomide was added to a group of 130 patients starting at 10 mg per day and increased to 20 mg as needed. An increase in ALT greater than or equal to three times the ULN was observed in 3.8% of patients compared to 0.8% in 133 patients continued on methotrexate with ...
124 more results from this site ▶

In a 6 month study of 263 patients with persistent active rheumatoid arthritis despite methotrexate therapy, and with normal LFTs, leflunomide was added to a group of 130 patients starting at 10 mg ...

www.fda.gov/medwatch/safety/2007/Nov_PI/Arava_PI.pdf

If a patient taking ARAVA develops any of these conditions, ARAVA therapy should be stopped

Nov 2007 | U.S. Food and Drug Administration – 124 more results from this site
Original Url: http://www.fda.gov/medwatch/safety/2007/Nov_PI/Arava_PI.pdf
Related searches: arthritis therapeutics, ankylosing spondyliti (bekhterev' disease), doramectin vet, age distribution of patients with community-acquired pneumonia, angina therapy

Hints & help

Language. English only please... for now.
Phrase search. You can use double quotes to make phrases (e.g. "mobile phones").
Booleans. You can use a plus ‘+’ to make a word mandatory, or a minus ‘–‘ to exclude it (e.g. +gas –oil production)
Vocabulary. We have only limited synonyms - please try different words in your query.
Questions? Please email us: helpdesk [at] zanran [dot] com